ChemFeeds Site Navigation:
Journal Selection:
Search:

1) Suppression of Breast and Colon Cancer Models Using RNAi (Molecular Cancer Therapeutics) Wednesday May 6th 2015


2) Oncolytic Activity of rNDV-B1/Fas (Molecular Cancer Therapeutics) Wednesday May 6th 2015


3) MGMT-Mediated Response to Temozolomide and PARP Inhibitors (Molecular Cancer Therapeutics) Wednesday May 6th 2015


4) Frequent TSC2 Loss in HCC and Everolimus Response (Molecular Cancer Therapeutics) Wednesday May 6th 2015


5) Druggable Vulnerabilities in E-Cadherin-Deficient Cells (Molecular Cancer Therapeutics) Wednesday May 6th 2015


6) Loss of NISCH Promotes Proliferation and Invasion (Molecular Cancer Therapeutics) Wednesday May 6th 2015


7) Endostatin Has Novel ATPase Activity (Molecular Cancer Therapeutics) Wednesday May 6th 2015


8) Imatinib and Dasatinib Reduce Myeloid Suppressor Cells (Molecular Cancer Therapeutics) Wednesday May 6th 2015


9) Targeting AKT for Glioblastoma Radiosensitization (Molecular Cancer Therapeutics) Wednesday May 6th 2015


10) HOTAIR and PCBP1 in Gastric Cancer (Molecular Cancer Therapeutics) Wednesday May 6th 2015


11) {beta}III-Tubulin Regulates Brain Metastases (Molecular Cancer Therapeutics) Wednesday May 6th 2015


12) ABT-806: A Tumor-Selective EGFR-Targeting Antibody (Molecular Cancer Therapeutics) Wednesday May 6th 2015


13) Tissue Factor Antibody-Drug Con{#x0237}ugate (Molecular Cancer Therapeutics) Wednesday May 6th 2015


14) Aurora Kinase Inhibition in Triple-Negative Breast Cancer (Molecular Cancer Therapeutics) Wednesday May 6th 2015


15) Targeting Hsp27 in NSCLC (Molecular Cancer Therapeutics) Wednesday May 6th 2015


16) P7170, a Novel Potent mTORC1/C2 and ALK1 Inhibitor (Molecular Cancer Therapeutics) Wednesday May 6th 2015


17) Targeting Wnts at the Source (Molecular Cancer Therapeutics) Wednesday May 6th 2015


18) Multifunctional Micelles for the Reversal of Drug Resistance (Molecular Cancer Therapeutics) Thursday April 9th 2015


19) (CAG)n and Protein Expression of AR in Colorectal Cancer (Molecular Cancer Therapeutics) Thursday April 9th 2015


20) BLM in Breast Cancer (Molecular Cancer Therapeutics) Thursday April 9th 2015


21) Biomarkers Change in Response to Bevacizumab and Everolimus (Molecular Cancer Therapeutics) Thursday April 9th 2015


22) Targeting JAK/STAT3 Inhibits Ovarian Cancer (Molecular Cancer Therapeutics) Thursday April 9th 2015


23) Integrin-Linked Kinase in RCC (Molecular Cancer Therapeutics) Thursday April 9th 2015


24) Dual PI3K/mTOR Inhibitors Enhance ERK Activation via mTORC2 (Molecular Cancer Therapeutics) Thursday April 9th 2015


25) p53-Dependent G2 Phase Arrest by FTD (Molecular Cancer Therapeutics) Thursday April 9th 2015


26) OATPs and Docetaxel Disposition (Molecular Cancer Therapeutics) Thursday April 9th 2015


27) An IGF-Trap for Cancer Treatment (Molecular Cancer Therapeutics) Thursday April 9th 2015


28) PAPP-A as a Therapeutic Target for Ovarian Cancer (Molecular Cancer Therapeutics) Thursday April 9th 2015


29) Nonclinical Evaluation of the Anti-SEMA4D Antibody VX15/2503 (Molecular Cancer Therapeutics) Thursday April 9th 2015


30) Acquired Resistance to Trastuzumab-ADC (Molecular Cancer Therapeutics) Thursday April 9th 2015


31) C4.4A Is the Functional Receptor of AGR2 (Molecular Cancer Therapeutics) Thursday April 9th 2015


32) Pharmacodynamics and Antitumor Efficacy of XL147 (SAR245408) (Molecular Cancer Therapeutics) Thursday April 9th 2015


33) Carboplatin {+/-} ABT888 in BRCA and Non-BRCA Intracranial TNBC (Molecular Cancer Therapeutics) Thursday April 9th 2015


34) IKK{beta} Regulates VEGF Expression (Molecular Cancer Therapeutics) Thursday April 9th 2015


35) Choline Kinase Inhibition for Treatment of Brain Tumors (Molecular Cancer Therapeutics) Thursday April 9th 2015


36) PARP Inhibitor and 5FU in the Treatment of Acute Leukemias (Molecular Cancer Therapeutics) Thursday April 9th 2015


37) ATF4 Mediates Cellular Response to YW3-56 (Molecular Cancer Therapeutics) Thursday April 9th 2015


38) Functional Genetic WEE1 Sensitivity Screen (Molecular Cancer Therapeutics) Thursday April 9th 2015


39) Preclinical Evaluation of Letrozole for Glioma Treatment (Molecular Cancer Therapeutics) Thursday April 9th 2015


40) PD-L1 IHC as a Predictive Biomarker in Cancer Immunotherapy (Molecular Cancer Therapeutics) Thursday April 9th 2015


41) Correction: MEDI-573, Alone or in Combination with Mammalian Target of Rapamycin Inhibitors, Targets the Insulin-like Growth Factor Pathway in Sarcomas (Molecular Cancer Therapeutics) Thursday March 12th 2015


42) CTC Detection by Microfiltration and Adenoviral Imaging (Molecular Cancer Therapeutics) Thursday March 12th 2015


43) CTA Expression in HNSCC (Molecular Cancer Therapeutics) Thursday March 12th 2015


44) Improved CTC Detection Using EpCAM and MCAM in Breast Cancer (Molecular Cancer Therapeutics) Thursday March 12th 2015


45) Synergistic EGFR and HER2 Blockade Enhances Radiation Effect (Molecular Cancer Therapeutics) Thursday March 12th 2015


46) Pdcd4 Enhances the Efficacy of OSI-906 in CRC (Molecular Cancer Therapeutics) Thursday March 12th 2015


47) Redox Modulation for Overcoming Gemcitabine Resistance (Molecular Cancer Therapeutics) Thursday March 12th 2015


48) Notch Activity Identifies Breast Cancer Stem Cells (Molecular Cancer Therapeutics) Thursday March 12th 2015


49) Targeting Androgen Receptor in Triple-Negative Breast Cancer (Molecular Cancer Therapeutics) Thursday March 12th 2015


50) Vemurafenib Resistance Signature in Melanoma (Molecular Cancer Therapeutics) Thursday March 12th 2015


51) Murine Ascites Enriches for Ovarian CSCs Expressing memGRP78 (Molecular Cancer Therapeutics) Thursday March 12th 2015


52) CD30 Expression in Mesothelioma (Molecular Cancer Therapeutics) Thursday March 12th 2015


53) HDAC6 Regulates Hh Signaling (Molecular Cancer Therapeutics) Thursday March 12th 2015


54) Stat5a/b Inhibition Potentiates Antiandrogen Therapy in Prostate Cancer (Molecular Cancer Therapeutics) Thursday March 12th 2015


55) Oncogenic Mechanisms and Prevalence of FGFR3-BAIAP2L1 (Molecular Cancer Therapeutics) Thursday March 12th 2015


56) SYD985 Is Effective in Low HER2-Expressing Breast Cancer (Molecular Cancer Therapeutics) Thursday March 12th 2015


57) Tumor Evasion of Antibody Immunity (Molecular Cancer Therapeutics) Thursday March 12th 2015


58) Superior HER2 Targeting by Antibody Mixtures (Molecular Cancer Therapeutics) Thursday March 12th 2015


59) Protease-Activated Peptides (Molecular Cancer Therapeutics) Thursday March 12th 2015


60) AMG 232 Regresses Tumors and Enhances Chemotherapy Efficacy (Molecular Cancer Therapeutics) Thursday March 12th 2015


61) Hsp70-Bag3 as a Protein-Protein Interaction Target (Molecular Cancer Therapeutics) Thursday March 12th 2015


62) Hedgehog Pathway Inhibitors and Basal Cell Carcinoma (Molecular Cancer Therapeutics) Thursday March 12th 2015


63) Predictive Biomarkers for IGF-1R/IR Inhibitor BMS-754807 in Colorectal Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


64) Targeting Wee-1 Kinase in mutp53 HNSCC (Molecular Cancer Therapeutics) Tuesday February 10th 2015


65) BRG1 Bromodomain Radiosensitizes Tumor Cells (Molecular Cancer Therapeutics) Tuesday February 10th 2015


66) Metformin Inhibits Rac1 GTPase and Cancer Cell Migration (Molecular Cancer Therapeutics) Tuesday February 10th 2015


67) Role of TDP1 and TOP1 in Colorectal Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


68) GSK3{beta} Sustains Glioblastoma Invasion (Molecular Cancer Therapeutics) Tuesday February 10th 2015


69) CD147 Promotes Radioresistance in HCC Cells (Molecular Cancer Therapeutics) Tuesday February 10th 2015


70) Sequential Anti-EGFR Therapy in Lung Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


71) Onartuzumab and Erlotinib Inhibits EGFR-Mutated NSCLC (Molecular Cancer Therapeutics) Tuesday February 10th 2015


72) Stromal HA Elevation Limits mAb-Mediated Cancer Therapy (Molecular Cancer Therapeutics) Tuesday February 10th 2015


73) Sunitinib Dose Escalation Overcomes Drug Resistance (Molecular Cancer Therapeutics) Tuesday February 10th 2015


74) Tumor-Suppressor Role of Notch3 in MTC (Molecular Cancer Therapeutics) Tuesday February 10th 2015


75) Targeted Lung Cancer Therapy with SapC-DOPS (Molecular Cancer Therapeutics) Tuesday February 10th 2015


76) Identification of a Novel CXCR4 Antagonist for Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


77) Structure-Based Design of Novel Antiangiogenic Biologics (Molecular Cancer Therapeutics) Tuesday February 10th 2015


78) Pazopanib/Paclitaxel Combination in Advanced Solid Tumors (Molecular Cancer Therapeutics) Tuesday February 10th 2015


79) PDT Targeting Tumor-Associated Macrophages (Molecular Cancer Therapeutics) Tuesday February 10th 2015


80) ALA Derivatives in the Treatment of Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


81) PI3K/mTOR Inhibition Radiosensitizes NPC (Molecular Cancer Therapeutics) Tuesday February 10th 2015


82) Targeting Tumor-Propagating Cells in Human Glioblastoma (Molecular Cancer Therapeutics) Tuesday February 10th 2015


83) Preclinical Studies of Anti-Pancreatic Tumor Agent SKLB261 (Molecular Cancer Therapeutics) Tuesday February 10th 2015


84) Inhibition of mTORC1 and mTORC2 in Sarcoma (Molecular Cancer Therapeutics) Tuesday February 10th 2015


85) SAR125844, a Selective Intravenous MET Kinase Inhibitor (Molecular Cancer Therapeutics) Tuesday February 10th 2015


86) AMG 925 Overcomes FLT3 Inhibitor Resistance (Molecular Cancer Therapeutics) Tuesday February 10th 2015


87) Efficacy of AZD1480 against JAK-Mutated ALL (Molecular Cancer Therapeutics) Tuesday February 10th 2015


88) Berberine Induces Senescence of Glioma Cells (Molecular Cancer Therapeutics) Tuesday February 10th 2015


89) NK150460: A Potential Antitumor Drug Activating AhR (Molecular Cancer Therapeutics) Tuesday February 10th 2015


90) High-Throughput Drug Screening for Novel Radiosensitizers (Molecular Cancer Therapeutics) Tuesday February 10th 2015


91) Efficacy of TAK-733 in Melanoma (Molecular Cancer Therapeutics) Tuesday February 10th 2015


92) BAI1 and Nestin in Breast Cancer Brain Metastases (Molecular Cancer Therapeutics) Wednesday January 14th 2015


93) Kinase Inhibitor Responses in Triple-Negative Breast Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


94) JAGGED2 Promotes Pancreatic Cancer Cell Migration (Molecular Cancer Therapeutics) Wednesday January 14th 2015


95) MET Amplification in Human and Murine Prostate Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


96) ANRIL Promotes Proliferation in NSCLC (Molecular Cancer Therapeutics) Wednesday January 14th 2015


97) Lack of NPP7 Enhances Colonic Tumorigenesis (Molecular Cancer Therapeutics) Wednesday January 14th 2015


98) LIM Kinases in Prostate Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


View: prev | next


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()